Running Oak Capital’s ResMed RMD Stock Holding History

Running Oak Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13M	Sell	57,797 -3,028	-5%	-$755K	1.75%	37
2025 Q4	$14.7M	Sell	60,825 -2,683	-4%	-$686K	1.84%	29
2025 Q3	$17.4M	Sell	63,508 -2,453	-4%	-$670K	1.95%	14
2025 Q2	$17M	Sell	65,961 -1,883	-3%	-$449K	1.89%	16
2025 Q1	$15.2M	Buy	+67,844	New	+$15.8M	1.83%	33

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Running Oak Capital's RMD Position: Q1 2026 in Review

Running Oak Capital reduced its ResMed (RMD) stake by 5% in Q1 2026, selling an estimated $755K and leaving 57,797 shares worth $13M. The position accounts for 1.75% of the portfolio, ranked #37.

Running Oak Capital first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $17.4M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Running Oak Capital held 57,797 shares of ResMed worth $13M as of Q1 2026.
Running Oak Capital sold 3,028 ResMed shares in Q1 2026, an estimated $755K.
ResMed made up 1.75% of Running Oak Capital's portfolio in Q1 2026, its #37 holding.
Running Oak Capital first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
Running Oak Capital's ResMed position peaked at $17.4M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Running Oak Capital's 13F filing for Q1 2026, filed 11 May 2026.